Michael Li, MD, MPH
banner
michael-li.bsky.social
Michael Li, MD, MPH
@michael-li.bsky.social
Transplant hepatologist and researcher at the University of California, San Francisco studying liver cancer and autoimmune liver disease. Harvard TH Chan, Brigham and Women’s, and Mount Sinai alum. #LiverSky
For anyone attending #NCCN2025 in Orlando, I'm excited to be speaking during the immune checkpoint inhibitor toxicities session at 1 pm on Friday 3/28. Looking forward to talking about immune-mediated hepatitis with an oncology audience!

@ucsfcancer.bsky.social #LiverSky
March 27, 2025 at 10:59 PM
And now NIH study sections are being canceled.

www.science.org/content/arti...
January 23, 2025 at 1:04 AM
@bloompringle.bsky.social trying to get the entire AASLD-EASL Masterclass to switch over to Bluesky! #Liversky
December 8, 2024 at 3:13 PM
Check out this Poster of Distinction by superstar UCSF intern and future hepatologist Isaac Benque on his work performing proteome-wide autoantibody discovery in PBC using phage immune precipitation sequencing! Really interesting novel diagnostic and prognostic hits.

#Liversky #TLM
November 18, 2024 at 10:23 PM
Great talks at #TLM this morning by Laura Kulik and Parissa Tabrizian about immunotherapy as part of downstaging strategies to liver transplantation or resection! Was nice to see our paper in JHep up on the screen, check it out here: www.journal-of-hepatology.eu/article/S016...

#Liversky
November 16, 2024 at 8:20 PM